Literature DB >> 25635382

Isomerism in benzyl-DOTA derived bifunctional chelators: implications for molecular imaging.

Katherine M Payne1, Mark Woods.   

Abstract

The bifunctional chelator IB-DOTA has found use in a range of biomedical applications given its ability to chelate many metal ions, but in particular the lanthanide(III) ions. Gd(3+) in particular is of interest in the development of new molecular imaging agents for MRI and is highly suitable for chelation by IB-DOTA. Given the long-term instability of the aryl isothiocyanate functional group we have used the more stable nitro derivative (NB-DOTA) to conduct a follow-up study of some of our previous work on the coordination chemistry of chelates of these BFCs. Using a combination of NMR and HPLC to study the Eu(3+) and Yb(3+) chelates of NB-DOTA, we have demonstrated that this ligand will produce two discrete regioisomeric chelates at the point at which the metal ion is introduced into the BFC. These regioisomers are defined by the position of the benzylic substituent on the macrocyclic ring: adopting an equatorial position either at the corner or the side of the [3333] ring conformation. These regioisomers are incapable of interconversion and are distinct, separate structures with different SAP/TSAP ratios. The side isomer exhibits an increased population of the TSAP isomer, pointing to more rapid water exchange kinetics in this regioisomer. This has potential ramifications for the use of these two regioisomers of Gd(3+)-BFC chelates in MRI applications. We have also found that, remarkably, there is little or no freedom of rotation about the first single bond extending from the macrocyclic ring to the benzylic substituent. Since this is the linkage through which the chelate is conjugated to the remainder of the molecular imaging probe, this result implies that there may be reduced local rotation of the Gd(3+) chelate within a molecular imaging probe. This implies that this type of BFC could exhibit higher relaxivities than other types of BFC.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25635382     DOI: 10.1021/bc500593h

Source DB:  PubMed          Journal:  Bioconjug Chem        ISSN: 1043-1802            Impact factor:   4.774


  4 in total

Review 1.  Ligand design strategies to increase stability of gadolinium-based magnetic resonance imaging contrast agents.

Authors:  Thomas J Clough; Lijun Jiang; Ka-Leung Wong; Nicholas J Long
Journal:  Nat Commun       Date:  2019-03-29       Impact factor: 14.919

2.  Automated GMP compliant production of [18F]AlF-NOTA-octreotide.

Authors:  Térence Tshibangu; Christopher Cawthorne; Kim Serdons; Elin Pauwels; Willy Gsell; Guy Bormans; Christophe M Deroose; Frederik Cleeren
Journal:  EJNMMI Radiopharm Chem       Date:  2020-01-29

3.  FAPI-04 PET/CT Using [18F]AlF Labeling Strategy: Automatic Synthesis, Quality Control, and In Vivo Assessment in Patient.

Authors:  Xiao Jiang; Xiaoxiong Wang; Taipeng Shen; Yutang Yao; Meihua Chen; Zeng Li; Xiuli Li; Jiaqi Shen; Ying Kou; Shirong Chen; Xing Zhou; Zhifu Luo; Zhuzhong Cheng
Journal:  Front Oncol       Date:  2021-03-19       Impact factor: 6.244

4.  Chiral DOTA chelators as an improved platform for biomedical imaging and therapy applications.

Authors:  Lixiong Dai; Chloe M Jones; Wesley Ting Kwok Chan; Tiffany A Pham; Xiaoxi Ling; Eric M Gale; Nicholas J Rotile; William Chi-Shing Tai; Carolyn J Anderson; Peter Caravan; Ga-Lai Law
Journal:  Nat Commun       Date:  2018-02-27       Impact factor: 14.919

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.